Rifaximin API Market Rifaximin API Market Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031 Request Sample Report
Rifaximin API Market Size and Growth
The global Rifaximin API market is anticipated to witness strong growth during the forecast period due to increasing prevalence of gastrointestinal disorders. The market size is expected to reach USD 300 million by 2025, driven by rising demand for effective treatment options and growing awareness about the benefits of Rifaximin API. Request
Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Salix Pharmaceuticals
◍ Lupin
◍ LGM Pharma
◍ B Joshi Agrochem Pharma
◍ Triveni Interchem
Competitive Landscape: Salix Pharmaceuticals, Lupin, LGM Pharma, B Joshi Agrochem Pharma, Triveni Interchem operate in the Rifaximin API Market. These companies develop and supply rifaximin API for pharmaceutical use. They contribute to the growth of the market by offering high-quality products and expanding their market reach.
- Salix Pharmaceuticals: $4.7 billion
- Lupin: $2.3 billion Request Sample Report
Market Segmentation
By Application
◍ Pharmaceuticals
◍ Others
By Product
◍ 99% Purity
◍ >99% Purity
Request Sample Report
$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients